VitraFy Life Sciences Limited has successfully quoted 769,142 new ordinary fully paid shares on the Australian Securities Exchange (ASX) as part of a securities purchase plan, initially announced on June 12, 2026. Priced at AUD 2.60 each, this move aims to bolster the company’s capital base, enabling further investments in research and development, and enhancing its market position in the life sciences sector. With the total number of quoted shares now reaching 62,253,342, investors should monitor potential impacts on share price and the strategic deployment of the raised capital. While the initiative signals financial health, inherent risks in the life sciences industry could affect outcomes.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://kalkine.com.au/news/announcements/vitrafy-life-sciences-expands-capital-with-new-quotation-of-securities
